Each year, the Integrated Veterinarians Australia (IVA) Special Interest Group of the Australian Veterinary Association (AVA) awards a $1,000 IVA Research Bursary to support projects, research, and science‑based communications related to integrative veterinary medicine.
In 2025, we are pleased to introduce a second bursary: The Dogs in Sync IVA Integrative Cancer Research Bursary, advancing evidence‑based integrative oncology for the veterinary community.
Dogs in Sync IVA Integrative Cancer Research Bursary
This bursary provides financial support for the development and dissemination of high-quality research that helps veterinarians better understand the role, efficacy, and evidence behind complementary therapies in cancer care.
By encouraging rigorous investigation and clear communication, the bursary aims to:
- Advance scientific knowledge in integrative veterinary oncology
- Promote evidence-based approaches to cancer treatment and supportive care
- Support the recognition of safe and effective integrative therapies within veterinary medicine
- Improve access to reliable information for the broader veterinary community
IVA Research Bursary
The IVA Research Bursary supports the preparation of educational or research‑based material that informs veterinarians about the use, effectiveness, and scientific validity of complementary therapies.
Projects may contribute to:
- Strengthening the scientific understanding of integrative therapies
- Supporting evidence‑based veterinary practice
- Increasing recognition and acceptance of integrative treatment modalities
The 1st 2025 recipient is Dr Susan Peden – Susan will be presenting a webinar “The Relevance of administration of a Probiotic (Limosilactobacillus reuteri) in Relieving Musculoskeletal Pain in Horses” on the 25th August. Registrations can be made via the AVA Education and Events website.
The 2nd 2025 receipent is Dr Matt Muir – Matt will be presenting a webinar in early December 2026 on “Integratgive Oncology in Practice: A 12-month obdservational experience using a proprietary mushroom-based nutraceuticdal in dogs with stage 2 splenic hemangiosarcoma”
The successful applicant will deliver one of the following outcomes:
- Research and then a poster for the following year AVA conference.
- Research and then a one hour webinar (longer if you wish!).
- Any other project that meets the objectives of the bursary – we encourage innovation!
We extend our thanks to Canine Ceuticals, the official sponsor of the 2025 IVA Bursary Program, for their support of evidence-based integrative veterinary research and education.
For more information please visit: https://www.ava.com.au/community/sig/integrative/iva-research-bursaries